Seer (SEER) Gross Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Seer (SEER) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 1,966.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 228.00 |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | -475.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 1,034.00 |
| 10 | Seer | 107.57 Mn | 107.57 Mn | 1.51 Mn | -356.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -356.00 |
| Mar 31, 2026 | -1,385.00 |
| Dec 31, 2025 | 134.00 |
| Sep 30, 2025 | 314.00 |
| Jun 30, 2025 | -424.00 |
| Mar 31, 2025 | 462.00 |
| Dec 31, 2024 | 554.00 |
| Sep 30, 2024 | -374.00 |
| Jun 30, 2024 | -56.00 |
| Mar 31, 2024 | -663.00 |
| Dec 31, 2023 | -475.00 |
| Sep 30, 2023 | 262.00 |
| Jun 30, 2023 | 1,248.00 |
| Mar 31, 2023 | 1,346.00 |
| Dec 31, 2022 | 310.00 |
| Sep 30, 2022 | -507.00 |
| Jun 30, 2022 | -1,164.00 |
| Mar 31, 2022 | -6,244.00 |
| Dec 31, 2021 | -5,326.00 |
| Sep 30, 2021 | -4,575.00 |